BUSINESS● LOW3h ago · Sep 22, 2026, 1:02 PM
Compass Therapeutics drops as FDA seeks additional trial for lead asset
Seeking Alpha Tech · north america
Compass Therapeutics' stock dropped after the FDA requested an additional trial for its lead asset.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS18m agoDrop in demand for wine has California farmers struggling to sell grapes this harvest seasonThe Independent WorldBUSINESS26m agoPrada’s Skirts Take Centre Stage As Milan Fashion Week BeginsChannels TV